Search
Close this search box.

South Korea Eases Discount Rate Rules to Support Non-Life Insurers

Seoul: The recent easing of discount rate regulations by South Korea's financial authorities will alleviate pressure on the solvency position of the country's non-life insurers, according to a new AM Best commentary. The financial adjustments are a response to the ongoing challenges posed by declining market interest rates and the stricter discount rate calculation for insurance liabilities imposed by domestic regulators.

According to BERNAMA News Agency, AM Best highlighted that the country's non-life insurers are experiencing increased solvency pressures. The planned regulatory changes are expected to decelerate the rate at which these pressures take effect, thereby easing the burden on insurers as they work to maintain their solvency positions. In the non-life insurance sector, the discount rate used in liability valuation is crucial for determining balance sheet strength under both IFRS 17 and the Korean Insurance Capital Standard (K-ICS), particularly due to the prevalence of long-term contracts.

The global credit rating agency noted that the Financial Supervisory Service (FSS) has played a significant role in setting discount rate standards to enhance comparability within the industry. Initially, the FSS had planned for a gradual implementation of the IFRS 17 accounting standards in 2023, with a phased reduction in discount rates scheduled to continue until 2027. However, unexpectedly rapid declines in interest rates have prompted a revision of these plans.

South Korea's 10-year treasury bond yield decreased from 3.85 per cent in August 2023 to 2.56 per cent by the end of April 2025, before partially rebounding to 3.34 per cent in early December 2025. This unforeseen decline in interest rates has led the FSS to reassess its strategy for lowering the discount rate, opting to slow the pace of implementation in response to industry feedback and to mitigate excessive capital pressures on non-life insurers.

Recent News

ADVERTISMENT